Literature DB >> 31552694

Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.

Sorina Chiorean1, Isaac Antwi1, Daniel W Carney2, Ioli Kotsogianni3, Andrew M Giltrap4, Francesca M Alexander5, Stephen A Cochrane5, Richard J Payne4, Nathaniel I Martin3, Antoine Henninot2, John C Vederas1.   

Abstract

The prevalence of life-threatening, drug-resistant microbial infections has challenged researchers to consider alternatives to currently available antibiotics. Teixobactin is a recently discovered "resistance-proof" antimicrobial peptide that targets the bacterial cell wall precursor lipid II. In doing so, teixobactin exhibits potent antimicrobial activity against a wide range of Gram-positive organisms. Herein we demonstrate that teixobactin and several structural analogues are capable of binding lipid II from both Gram-positive and Gram-negative bacteria. Furthermore, we show that when combined with known outer membrane-disrupting peptides, teixobactin is active against Gram-negative organisms.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; antimicrobial resistance; macrocyclic peptides; medicinal chemistry; peptides

Mesh:

Substances:

Year:  2019        PMID: 31552694     DOI: 10.1002/cbic.201900504

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism.

Authors:  Qianhui Wu; Biswajit Mishra; Guangshun Wang
Journal:  Pept Sci (Hoboken)       Date:  2022-04-25

Review 2.  Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields.

Authors:  Antonio Moretta; Carmen Scieuzo; Anna Maria Petrone; Rosanna Salvia; Michele Dario Manniello; Antonio Franco; Donatella Lucchetti; Antonio Vassallo; Heiko Vogel; Alessandro Sgambato; Patrizia Falabella
Journal:  Front Cell Infect Microbiol       Date:  2021-06-14       Impact factor: 5.293

Review 3.  Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.

Authors:  Charlotte M J Wesseling; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-08-10       Impact factor: 5.578

Review 4.  The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria.

Authors:  Samantha J Bann; Ross D Ballantine; Stephen A Cochrane
Journal:  RSC Med Chem       Date:  2021-01-22

Review 5.  Emerging peptide antibiotics with therapeutic potential.

Authors:  Gregory Upert; Anatol Luther; Daniel Obrecht; Philipp Ermert
Journal:  Med Drug Discov       Date:  2020-12-30

6.  Brevibacillin 2V Exerts Its Bactericidal Activity via Binding to Lipid II and Permeabilizing Cellular Membranes.

Authors:  Xinghong Zhao; Xiaoqi Wang; Rhythm Shukla; Raj Kumar; Markus Weingarth; Eefjan Breukink; Oscar P Kuipers
Journal:  Front Microbiol       Date:  2021-07-16       Impact factor: 5.640

7.  Rondonin: antimicrobial properties and mechanism of action.

Authors:  Katie C T Riciluca; Ursula C Oliveira; Ronaldo Z Mendonça; José C Bozelli Junior; Shirley Schreier; Pedro I da Silva Junior
Journal:  FEBS Open Bio       Date:  2021-08-19       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.